Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 01-31.
Amounts in USD.
Revenue Quarterly
0
80M
160M
240M
Q2 '22: 207.7M
Q3 '22: 172.2M
Q4 '22: 176.2M
Q1 '23: 206.7M
Q2 '23: 196.9M
Q3 '23: 176.6M
Q4 '23: 179M
Q1 '24: 192.1M
Q2 '24: 182.9M
Q3 '24: 158.3M
Q1 '25: 174.9M
Q2 '25: 177.1M
Q3 '25: 168.6M
Q4 '25: 146.2M
Q1 '26: 157.9M
Q2 '26: 170.2M
Q3 '26: 176.5M
Q4 '26: 155.4M
Q4 '26: 151.7M
Q2 '27: 171.1M
Q3 '22
Q2 '23
Q1 '24
Q1 '25
Q4 '25
Q3 '26
Q2 '27
Gross Profit Quarterly
0
50M
100M
150M
Q1 '17: 124M
Q2 '17: 89.8M
Q3 '17: 75.6M
Q4 '17: 65.1M
Q1 '18: 94M
Q2 '18: 65.7M
Q3 '18: 65.8M
Q1 '19: 71.5M
Q2 '19: 96M
Q3 '19: 79.1M
Q4 '19: 67M
Q1 '20: 65M
Q2 '20: 94.3M
Q3 '20: 82.2M
Q4 '20: 72.9M
Q1 '21: 67.1M
Q2 '21: 17.1M
Q3 '21: 35.4M
Q3 '21: 41.4M
Q4 '21: 48M
Q2 '17
Q1 '18
Q1 '19
Q4 '19
Q3 '20
Q2 '21
Q4 '21
Operating Income Quarterly
-18M
-9M
0
9M
18M
27M
Q2 '22: 23.8M
Q2 '22: 18.6M
Q3 '22: 2.9M
Q1 '23: 11.7M
Q2 '23: 3.4M
Q3 '23: -9.1M
Q4 '23: -9.6M
Q1 '24: 6.6M
Q2 '24: 2.5M
Q3 '24: -10.3M
Q1 '25: -16.6M
Q2 '25: 6.1M
Q3 '25: -623K
Q4 '25: -17M
Q1 '26: -14.9M
Q2 '26: 3.4M
Q3 '26: 5.5M
Q4 '26: -8.2M
Q4 '26: -13.5M
Q2 '27: 9M
Q2 '22
Q2 '23
Q1 '24
Q1 '25
Q4 '25
Q3 '26
Q2 '27
Net Income Quarterly
-24M
-16M
-8M
0
8M
16M
24M
Q2 '22: 20.7M
Q2 '22: 14M
Q3 '22: 8.6M
Q1 '23: 9.7M
Q2 '23: -2.3M
Q3 '23: -4.5M
Q4 '23: -3M
Q1 '24: 4.4M
Q2 '24: 1.1M
Q3 '24: -6.1M
Q1 '25: -23.4M
Q2 '25: 11M
Q3 '25: 95K
Q4 '25: -15.1M
Q1 '26: -14.1M
Q2 '26: 3.3M
Q3 '26: 6.8M
Q4 '26: -5.2M
Q4 '26: -10.9M
Q2 '27: 9.3M
Q2 '22
Q2 '23
Q1 '24
Q1 '25
Q4 '25
Q3 '26
Q2 '27
Cost of Revenue Quarterly
0
50M
100M
150M
Q2 '22: 115.6M
Q3 '22: 104.2M
Q4 '22: 109.6M
Q1 '23: 132.2M
Q2 '23: 131.7M
Q3 '23: 123.8M
Q4 '23: 121.9M
Q1 '24: 122.1M
Q2 '24: 117.6M
Q3 '24: 105.8M
Q1 '25: 118.8M
Q2 '25: 112.5M
Q3 '25: 109.1M
Q4 '25: 103M
Q1 '26: 111.9M
Q2 '26: 109.3M
Q3 '26: 111.5M
Q4 '26: 104.5M
Q4 '26: 106.2M
Q2 '27: 106.3M
Q3 '22
Q2 '23
Q1 '24
Q1 '25
Q4 '25
Q3 '26
Q2 '27
Operating Cash Flow Quarterly
-30M
-15M
0
15M
30M
45M
Q2 '22: 37.5M
Q3 '22: -2.5M
Q4 '22: -19.6M
Q1 '23: -765K
Q2 '23: 17.7M
Q3 '23: 2.3M
Q4 '23: -5.9M
Q1 '24: 9.9M
Q2 '24: 11.7M
Q3 '24: -9.9M
Q1 '25: -11.2M
Q2 '25: 5.7M
Q3 '25: 3.1M
Q4 '25: -22.1M
Q1 '26: -6.5M
Q2 '26: 3.9M
Q3 '26: 11.8M
Q4 '26: -12.4M
Q4 '26: -4.7M
Q2 '27: 8M
Q3 '22
Q2 '23
Q1 '24
Q1 '25
Q4 '25
Q3 '26
Q2 '27
Free Cash Flow Quarterly
-30M
-15M
0
15M
30M
45M
Q2 '22: 36.9M
Q3 '22: -3.2M
Q4 '22: -21.9M
Q1 '23: -5.2M
Q2 '23: 11.8M
Q3 '23: -1.7M
Q4 '23: -11M
Q1 '24: 3.7M
Q2 '24: 9.4M
Q3 '24: -11.7M
Q1 '25: -13.5M
Q2 '25: 2.4M
Q3 '25: 1.6M
Q4 '25: -23.8M
Q1 '26: -7.8M
Q2 '26: 2.8M
Q3 '26: 10.4M
Q4 '26: -12.9M
Q4 '26: -5.6M
Q2 '27: 7M
Q3 '22
Q2 '23
Q1 '24
Q1 '25
Q4 '25
Q3 '26
Q2 '27
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
9M
18M
27M
Q4 '20: 23.7M
Q2 '21: 23M
Q3 '21: 22.9M
Q3 '21: 22.7M
Q2 '22: 21.5M
Q2 '22: 21.4M
Q3 '22: 21M
Q1 '23: 20.1M
Q2 '23: 20M
Q3 '23: 19.9M
Q1 '24: 19.3M
Q2 '24: 19.4M
Q3 '24: 19.4M
Q2 '25: 19.4M
Q3 '25: 19.3M
Q4 '25: 19.3M
Q2 '26: 18.7M
Q3 '26: 18.8M
Q4 '26: 18.8M
Q2 '27: 18.8M
Q2 '21
Q2 '22
Q1 '23
Q1 '24
Q2 '25
Q2 '26
Q2 '27
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
EPS TTM
-2.10
-1.40
-0.70
0.00
0.70
1.40
2.10
Q3 '21: -1.38
Q3 '21: -1.77
Q4 '21: -2.01
Q2 '22: 0.10
Q2 '22: 1.02
Q3 '22: 1.56
Q4 '23: 0.00
Q1 '24: -0.24
Q2 '24: -0.07
Q3 '24: -0.16
Q1 '25: -1.17
Q2 '25: -0.85
Q3 '25: -0.90
Q4 '25: -1.39
Q1 '26: -0.97
Q2 '26: -1.34
Q3 '26: -1.00
Q4 '26: -0.49
Q4 '26: -0.31
Q2 '27: -0.01
Q3 '21
Q2 '22
Q1 '24
Q1 '25
Q4 '25
Q3 '26
Q2 '27
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.